Northampton Electronic Collection of Theses and Research

Browse by Author or Creator

[up] Up a level
Group by: Item Type | Date
Jump to: Article | Monograph | Conference or Workshop Item
Number of items: 32.

Article

  1. Anthony, K., Ala, P., Catapano, F., Meng, J., Domingos, J., Perry, M., Ricotti, V., Maresh, K., Phillips, L., Servais, L., Seferian, A., De Lucia, S., de Groot, I., D Krom, Y., Verschuuren, J., Niks, E., Straub, V., Guglieri, M., Voit, T., Morgan, J. and Muntoni, F. (2022) T Cell Responses to Dystrophin in a Natural History Study of Duchenne Muscular Dystrophy. Human Gene Therapy. 1043-0342.
  2. Khalsan, M., Machado, L., SALIH AL-SHAMERY, E., Ajit, S., Anthony, K., Mu, M. and Opoku Agyeman, M. (2022) A Survey of Machine Learning Approaches Applied to Gene Expression Analysis for Cancer Prediction. IEEE Access. 2169-3536.
  3. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Scientific Reports. 12(1) 2045-2322.
  4. Anthony, K. (2022) RNA-based therapeutics for neurological diseases. RNA Biology. 19(1), pp. 176-190. 1547-6286.
  5. Wood, C. and Anthony, K. (2021) Regulation of the alternative splicing of Dp71, the major brain dystrophin transcript, by splicing factors. Neuromuscular Disorders. 31(1), S89-S90. 0960-8966.
  6. Jones, L., Naidoo, M., Machado, L. and Anthony, K. (2020) The Duchenne muscular dystrophy gene and cancer. Cellular oncology (Dordrecht). 44(1), pp. 19-32. 2211-3428.
  7. Naidoo, M. and Anthony, K. (2019) Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy. Molecular Neurobiology. , pp. 1-20. 0893-7648.
  8. Hiller, M., Falzarano, M. S., Garcia-Jimenez, I., Sardone, V., Verheul, R. C., Popplewell, L., Anthony, K., Ruiz-Del-Yerro, E., Osman, H., Goeman, J. J., Mamchaoui, K., Dickson, G., Ferlini, A., Muntoni, F., Aartsma-Rus, A., Arechavala-Gomeza, V., Datson, N. A. and Spitali, P. (2018) A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures. PLoS ONE. 13(10), pp. 1-15. 1932-6203.
  9. Hiller, M., Falzarano, M. S., Garcia-Jimenez, I., Sardone, V., Verheul, R. C., Popplewell, L., Anthony, K., Ruiz-Del-Yerro, E., Osman, H., Goeman, J. J., Mamchaoui, K., Dickson, G., Ferlini, A., Muntoni, F., Aartsma-Rus, A., Arechavala-Gomeza, V., Datson, N. A. and Spitali, P. (2018) A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures. PLoS ONE. 13(10), pp. 1-15. 1932-6203.
  10. Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 28(Sup. 1) 0960-8966.
  11. Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 28(Sup. 1) 0960-8966.
  12. Ash, A., Booth-Wynne, L. and Anthony, K. (2017) Brain involvement in Duchenne muscular dystrophy: a role for dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 27(Supp 2) 0960-8966.
  13. Ash, A., Booth-Wynne, L. and Anthony, K. (2017) Brain involvement in Duchenne muscular dystrophy: a role for dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 27(Supp 2) 0960-8966.
  14. Malmqvist, T., Spickett, C., Gallo, J.-M. and Anthony, K. (2017) A UV cross-linking method combined with infrared imaging to analyse RNA–protein interactions. Biology Methods & Protocols. 2(1), pp. 1-4. 2396-8923.
  15. Malmqvist, T., Spickett, C., Gallo, J.-M. and Anthony, K. (2017) A UV cross-linking method combined with infrared imaging to analyse RNA–protein interactions. Biology Methods & Protocols. 2(1), pp. 1-4. 2396-8923.
  16. Ricotti, V., Eagle, M., Butler, J., Decostre, V., Deborah, R., Moraux, A., Anthony, K., Sleby, V., Guglieri, M., Van der Holst, M., Jansen, M., Morgan, J., de Groot, I., Niks, E., Verschuuren, J., Servais, L., Hogrel, J. Y., Voit, T., Straub, V. and Muntoni, F. (2015) G.P.147 - Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials. Neuromuscular Disorders. 25(Supp 2) 0960-8966.
  17. Zaharieva, I., Cirak, S., Anthony, K., Feng, L., Tasca, G., Ferlini, A., Morgan, J. and Muntoni, F. (2015) G.P.228 - Micro RNA profile associated with the dystrophin level in Becker muscular dystrophy. Neuromuscular Disorders. 25(Supp 2) 0960-8966.
  18. Ricotti, V., Eagle, M., Butler, J., Decostre, V., Deborah, R., Moraux, A., Anthony, K., Sleby, V., Guglieri, M., Van der Holst, M., Jansen, M., Morgan, J., de Groot, I., Niks, E., Verschuuren, J., Servais, L., Hogrel, J. Y., Voit, T., Straub, V. and Muntoni, F. (2015) G.P.147 - Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials. Neuromuscular Disorders. 25(Supp 2), S229. 0960-8966.
  19. Zaharieva, I., Cirak, S., Anthony, K., Feng, L., Tasca, G., Ferlini, A., Morgan, J. and Muntoni, F. (2015) G.P.228 - Micro RNA profile associated with the dystrophin level in Becker muscular dystrophy. Neuromuscular Disorders. 25(Supp 2), S255. 0960-8966.
  20. Anthony, K., Arechavala-Gomeza, V., Taylor, L. E., Vulin, A., Kaminoh, Y., Torelli, S., Feng, L., Janghra, N., Bonne, G., Beuvin, M., Barresi, R., Henderson, M., Laval, S., Lourbakos, A., Campion, G., Straub, V., Voit, T., Sewry, C. A., Morgan, J. E., Flanigan, K. M. and Muntoni, F. (2014) Dystrophin quantification: biological and translational research implications. Neurology. 83(22) 0028-3878.
  21. Anthony, K., Arechavala-Gomeza, V., Taylor, L. E., Vulin, A., Kaminoh, Y., Torelli, S., Feng, L., Janghra, N., Bonne, G., Beuvin, M., Barresi, R., Henderson, M., Laval, S., Lourbakos, A., Campion, G., Straub, V., Voit, T., Sewry, C. A., Morgan, J. E., Flanigan, K. M. and Muntoni, F. (2014) Dystrophin quantification: biological and translational research implications. Neurology. 83(22) 0028-3878.
  22. Anthony, K., Arechavala-Gomeza, V., Taylor, L. E., Vulin, A., Kaminoh, Y., Torelli, S., Feng, L., Janghra, N., Bonne, G., Beuvin, M., Barresi, R., Henderson, M., Laval, S., Lourbakos, A., Campion, G., Straub, V., Voit, T., Sewry, C. A., Morgan, J. E., Flanigan, K. M. and Muntoni, F. (2014) Dystrophin quantification: biological and translational research implications. Neurology. 83(22) 0028-3878.
  23. Malmqvist, T., Anthony, K. and Gallo, J.-M. (2014) Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A. Brain Research. 1584, pp. 22-27. 0006-8993.
  24. Malmqvist, T., Anthony, K. and Gallo, J.-M. (2014) Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A. Brain Research. 1584, pp. 22-27. 0006-8993.
  25. Malmqvist, T., Anthony, K. and Gallo, J.-M. (2014) Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A. Brain Research. 1584, pp. 22-27. 0006-8993.
  26. Anthony, K., Arechavala-Gomeza, V., Ricotti, V., Torelli, S., Feng, L., Janghra, N., Tasca, G., Guglieri, M., Barresi, R., Armaroli, A., Ferlini, A., Bushby, K., Straub, V., Ricci, E., Sewry, C., Morgan, J. and Muntoni, F. (2014) Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to Exon 44 or 45 skipping. JAMA Neurology. 71(1), pp. 32-40. 2168-6149.
  27. Anthony, K., Arechavala-Gomeza, V., Ricotti, V., Torelli, S., Feng, L., Janghra, N., Tasca, G., Guglieri, M., Barresi, R., Armaroli, A., Ferlini, A., Bushby, K., Straub, V., Ricci, E., Sewry, C., Morgan, J. and Muntoni, F. (2014) Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to Exon 44 or 45 skipping. JAMA Neurology. 71(1), pp. 32-40. 2168-6149.

Monograph

  1. Poole, H., Sixsmith, J., Parkes, J., Ward, A., Pyer, M., Campbell, J., Machado, L., Rehling, T., Youell, J., Carter, J., Oyebode, J., O’Malley, M., Anthony, K., Rogers, S., Jones, J., Siddons, L., Smith, L.-A., Kay, A. D., Fraser, M., Score, J., El Khoury, L., Hameed, A., Albalbeisi, N., Durrant, L. G., Al-Zubaidi, R., Al-Rayahi, I., da Silva, K. and Taylor, J. (2017) Health and wellbeing amongst older people research in Northamptonshire.

Conference or Workshop Item

  1. Buijsen, R., Green, E., Avale, E., Gallo, J.-M. and Anthony, K. (2022) Evaluation of RNA trans-splicing as a therapeutic strategy for spinocerebellar ataxia type 1. Poster presented to: International Congress for Ataxia Research (ICAR), Dallas, Texas, U.S.A, 2022-11-01 - 2022-11-04.
  2. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Poster presented to: Cancer Research UK Brain Tumour Conference, 2022-09-05 - 2022-09-07.
  3. Robertson-Smith, B., McCulloch, T., Campbell, J., Anthony, K. and Ashford, R. (2021) Outcomes of treatment of synovial sarcoma. Other presented to: British Orthopaedic Oncology Society 2021, 2021-10-08.
  4. Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Poster presented to: 11th Annual Neuromuscular Translational Research Conference, Fitzwilliam College, Cambridge, 19-20 April 2018.
This list was generated from NECTAR on Thu Sep 4 01:33:03 2025 BST.